Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial. (Q48076549)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 May 2014

Language	Label	Description	Also known as
English	Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.	scientific article published on 14 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

(3aS)-palonosetron

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

12

object named as

Kosei Hasegawa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Hiroaki Itamochi

10

object named as

Hiroaki Itamochi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

7

object named as

Masashi Takano

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Nobuhiro Takeshima

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Maki Matoda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Masakazu Abe

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Yasuyuki Hirashima

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Kaei Nasu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Kenichi Furuya

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Seiya Sato

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Hiroshi Tsubamoto

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Kiminari Terao

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Takeo Otsuki

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Keiko Kuritani

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Kimihiko Ito

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

publication date

14 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

2891-2898

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24825735 AND SRC:MED&resulttype=core&format=json

18 March 2020

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1007/S00520-014-2280-6

21 January 2018

The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24825735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24825735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24825735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48076549&oldid=2209081570"